Wf. Lawrence et al., Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations, CANC EPID B, 10(5), 2001, pp. 475-481
Counseling and predictive testing are now available for the recently isolat
ed BRCA1 and BRCA2 breast cancer susceptibility genes. We examined the soci
etal casts of providing this counseling and testing to women at risk of hav
ing a breast cancer susceptibility mutation. Genetic counselors in a resear
ch program prospectively monitored the time necessary to provide counseling
and results disclosure, A time motion study was used to determine time spe
nt on phone calls, preparation, and documentation for counseling. Study par
ticipants were surveyed to determine travel time and need for dependent car
e during counseling. The test cost was calculated using the charge for full
BRCA1/2 gene sequencing (Myriad Genetics, Inc.) multiplied by a Medicare-b
ased cost-to-charge ratio. Counselors spent an average of 4.2 h providing g
enetic counseling for women at risk of having a susceptibility mutation. Ge
netic counseling without testing cost on average $213, whereas counseling,
testing, and disclosure of results totaled $2057, A brief physician-based c
ounseling instead of genetic counselor-based counseling would produce only
small reductions in total costs. Providing counseling and testing to the st
udy population averaged $8034 per mutation found. The cost of testing and c
ounseling exceeded $2000, The counseling portion of the cost comprised only
16% of the total cost, with the remainder representing costs associated wi
th testing; thus, alternatives to full genetic counseling that shorten coun
seling time are unlikely to have a large impact on the overall cost of coun
seling and testing. The cost of detecting a mutation within a population of
women is highly dependent on the prevalence of the mutation in the populat
ion.